Literature DB >> 33373985

Diagnostic Yield and Safety of Image-Guided Pleural Biopsy: A Systematic Review and Meta-Analysis.

Federico Mei1, Martina Bonifazi2,3, Matteo Rota4, Laura Cirilli3, Martina Grilli2, Claudia Duranti2, Lina Zuccatosta2, Eihab O Bedawi5, David McCracken5, Stefano Gasparini2,3, Najib M Rahman5,6.   

Abstract

BACKGROUND: Diagnostic yield (DY) and safety of computed tomography (CT)- and thoracic ultrasound (TUS)-guided biopsies in the diagnosis of pleural lesions have been investigated in a number of studies, but no synthesis of data from the literature has ever been performed.
OBJECTIVES: We aimed to provide the first systematic review and meta-analysis on the DY and safety of CT- versus TUS-guided biopsy in the diagnosis of pleural lesions.
METHOD: We searched MEDLINE and EMBASE for all studies reporting outcomes of interest published up to April 2018. Two authors reviewed all titles/abstracts and retrieved selected full text to identify studies according to predefined selection criteria. Summary estimates were derived using the random-effects model. Cumulative meta-analysis assessed the influence of increasing adoption of the procedures over time.
RESULTS: Thirty original studies were included in the present review; the number of studies on TUS-guided biopsy was almost three-fold higher than those on CT-guided biopsy. The pooled DYs of the 2 procedures were overall excellent and differed <10%, being 84% for TUS-guided biopsy and 93% for CT-guided biopsy. Safety profiles were reassuring for both the techniques, being 7 and 3% for CT- and TUS-guided biopsy, respectively. DY of ultrasound technique significantly improved over time, while no time effect was observed for CT-guided biopsy.
CONCLUSIONS: Data show that CT- and TUS-guided biopsies in the diagnosis of pleural lesions are both excellent procedures, without meaningful differences in DYs and safety. Considering that TUS is non-ionizing and easily performed at the bedside, it should be the preferred approach in presence of adequate skills.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Computed tomography-guided biopsy; Mesothelioma; Meta-analysis; Pleural diseases; Ultrasound-guided biopsy

Year:  2020        PMID: 33373985     DOI: 10.1159/000511626

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

Review 1.  Lung, Pleural, and Mediastinal Biopsies: From Preprocedural Assessment to Technique and Management of Complications.

Authors:  Natasha Larocque; Olga R Brook
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

2.  Surgical Diagnosis of Malignant Pleural Mesothelioma: 20 Years' Experience at a High-Volume Referral Center.

Authors:  Amedeo Iaffaldano; Thomas Charrier; Filippo Lococo; Diane Damotte; Antonio Bobbio; Marco Alifano; Ludovic Fournel
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241

3.  Pleural Involvement in IgG4-Related Disease: Case Report and Review of the Literature.

Authors:  Federico Mei; Massimiliano Mancini; Giulio Maurizi; Andrea Vecchione; Lina Zuccatosta; Erino Angelo Rendina; Stefano Gasparini
Journal:  Diagnostics (Basel)       Date:  2021-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.